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Recovery of cell subpopulations from human tumour
xenografts following dissociation with different enzymes
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Summary Human epidermoid tumours (Coll2, HEp3, A431, ME18O) grown in nude mice were dissociated
using four different enzyme cocktails: (1) 0.025% collagenase, 0.05% pronase, 0.04% DNase; (2) 0.1%
protease IX; (3) 0.14% trypsin, 0.04% DNase; (4) 0.025% collagenase, 0.02% DNase. Using these different
enzymatic procedures, the total cell yields, host to tumour cell ratios, plating efficiencies and cell cycle
distribution profiles obtained from each tumour model were compared. For all tumours tested, enzyme
cocktail 1 was the most effective in releasing the greatest total number of cells g 1 tumour. However, for each
tumour the percentage of neoplastic cells recovered, the plating efficiency and the cell cycle distributions
varied according to the enzyme cocktail used to dissociate the tumour. For example, for HEp3 tumours, the
highest plating efficiency was achieved using enzyme cocktail 4, whereas for ME180 tumours, this enzyme
cocktail produced the lowest plating efficiency. Further, the effect of lethally irradiated (HR) feeder cells on
the plating efficiency of the various tumours was found to be influenced by the enzymes chosen to dissociate
the tumours. These studies indicate that the choice of an enzyme dissociation technique may profoundly
influence the results obtained using human tumour xenografts.
The growth of human tumours in nude mice has
been developed as a model to study the in vivo
effects of chemotherapeutic agents, ionizing radia-
tion, and biological response modifiers on human
neoplasms (reviewed by Steel & Peckham, 1980;
Fogh & Giovanella, 1977). Unlike murine tumour
models, no standardized techniques have been
developed for the dissociation of human tumour
material. Instead, a wide assortment of enzymes
used either alone or as enzyme cocktails, have been
utilized to isolate single cell suspensions from solid
tumours. It has been tacitly assumed that these
enzyme dissociation techniques will provide opti-
mum neoplastic cell recovery with minimal effects
on the biological endpoint being studied. This has
not, however, always been observed to be the case
in rodent tumours (Siemann et al., 1981; Ng, 1978;
Twentyman et al., 1980). Further, Rasey and Nelson
(1980) have demonstrated differences in both cell
yield and plating efficiency of cyclophosphamide-
or bleomycin-treated murine tumours following
dissociation with an enzyme cocktail as compared
to dissociation with trypsin alone. More recently,
Engelholm et al. (1985) have demonstrated that for
human tumours, long-term trypsinization procedures
resulted in more representative cell yields, as
judged by flow cytometry, than did short-term
trypsinization or mechanical disaggregation. Because
of the suggestion that the choice of a tumour
dissociation technique may significantly modify
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tumour cell recovery, we have chosen to compare
the use of four standard enzyme dissociation
techniques on the total cell recovery, host versus
neoplastic cell ratio, plating efficiency and cell cycle
distribution of four human epidermoid cell tumours
grown in nude mice.
Materials and methods
Tumours
Cells obtained from established tumour cell lines
were grown .as tumours in female nude mice
(NCR-nu) maintained in a humidified, aseptic
environment. Four epidermoid cell lines were used:
Col12, derived from a colon carcinoma (Mach et
al., 1974); HEp3, derived from a metastatic buccal
mucosa carcinoma (Toolan, 1954); A431, derived
from a vulvar carcinoma (Giard et al., 1973) and
ME180, derived from a cervix carcinoma (Sykes et
al., 1970). Cells in the exponential phase of growth
were injected s.c. into the axilla region of the mice,
with each mouse bearing bilateral tumours. Tumour
volumes were determined at 3 to 4 day intervals.
Tumours were an average of 900mm3 at the time
of excision. Four or more tumours were used for
each experiment.
Dissociation techniques
After weighing, each tumour was cut into four
equal pieces, with each tumour quarter being
assigned to one of the four enzyme dissociation
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groups. This was done in an attempt to ensure an
equal distribution of tumour material among the
four dissociation groups being tested. The tumour
quarters were finely minced with surgical scissors
and then were transferred to 35ml aliquots of each
of the following enzyme cocktails: (1) 0.025%
collagenase (Sigma), 0.05% pronase (Calbiochem-
Behring), 0.04% DNase (Sigma); (2) 0.1% protease
IX (Sigma); (3) 0.14% trypsin (Gibco), 0.04%
DNase; (4) 0.025% collagenase, 0.02% DNase. The
enzyme preparations were incubated at 37°C with
constant agitation for 1 h. Following incubation,
the tumour suspensions were passed through 200
gauge mesh screens to remove any residual tissue
clumps. The cell suspensions were washed free of
enzymes, resuspended in complete media (alpha-
MEM with 10% foetal calf serum) and held on ice.
Samples of cells prepared by each enzyme technique
were counted with a haemocytometer using a dye
exclusion technique and then diluted to the
appropriate cell concentrations required for in vitro
clonogenic assays, flow cytometric (FCM) analysis
and cellular morphology assessment using
Wright/Giemsa stained cytocentrifuge preparations.
Clonogenic assay
The plating efficiency of the cell suspensions
obtained using each enzyme cocktail was
determined using a double agar layer assay. Briefly,
2ml underlayers consisting of 0.5% agar in
complete media were prepared in 6-well multiwell
tissue culture plates. Following solidification of the
underlayer, 5 x 102 to 5 x 103 cells were added in a
2ml volume of 0.33% agar in complete media.
Plates were incubated at 37°C in an atmosphere of
5% CO2 in air for three weeks. Colonies of 50 or
more cells were counted with the aid of a dissecting
microscope.
FCM analysis
FCM measurements of methanol-fixed cell
suspensions obtained using each enzyme
dissociation cocktail were determined using
mithramycin staining and an EPICS V flow
cytometer (Coulter Electronics, Inc.). DNA
histograms were analyzed according to the model of




For all tumours tested, the use of enzyme cocktail 1
(0.025% collagenase, 0.05% pronase, 0.04%
DNase) was the most effective, resulting in
approximately two times more cells (i.e. 107 cells)
recovered per gram of tumour than could be
achieved using cocktails 2-4 (Figure 1). Variable
cell yields were achieved using cocktails 2-4, with
no single preparation of enzymes being equally
effective in all of the tumours tested.
Enzyme cocktail I was also equally or more








CoIl2 HEp3 A431 ME180
Figure 1 Total cell recovery following dissociation of tumours with different enzyme cocktails. Mean+s.e.
provided for three or more determinations. Enzyme cocktail 1 (-); 2 (a); 3 (l); 4 (O7).XENOGRAFT CELL RECOVERY AFTER ENZYME DISSOCIATION 617
Table I Cell types present following tumour dissociation with different enzyme
cocktails. Mean+s.e. provided for three or more determinations.
Enzyme
cocktail % Tumour % Macrophage % Neutrophil % Lymphocyte
Coll2 1 78+3 20+3 2+0.3 1 +0.5
2 63+3a 32+3a 3+0.5 2+0.5
3 76+2 20+2 1+0.3 3+1
4 71+4 23+2 4+1 3+0.7
HEp3 1 64+8 20+1 13+7 3+1
2 72+ 12 12+1 16+12 1+1
3 61+5 28+2 10+4 2+1
4 70+7 14+1 15+8 2+0.5
A431 1 55+6 24+3 17+6 4+2
2 10+3a 17+4 71 +5a 1+1
3 45+7 20+4 30+ 12 4+3
4
ME180 1 68+ 10 26+7 0.2+0.1 6+3
2 58+3 38+ 1 2+ 1 2+1
3 53+ 10 37+8 7+3 2+1
4 50 46 4 1
aIndicates values which are significantly different (P<0.05) from
enzyme cocktail 1.
numbers of neoplastic cells from each tumour
(Table I), although for Col.12, HEp3 and ME180
tumours, the variation in tumour cell recovery was
small when the four enzyme cocktails were
compared. However, for A431 tumours, only
enzyme cocktails 1 and 3 were able to release
appreciable numbers of tumour cells. The use of
enzyme cocktail 4 with A431 tumours consistently
resulted in cell preparations containing large
numbers of damaged and lysed cells and few
recognizably intact tumour cells.
Clonogenic assays
Following dissociation with enzyme cocktail 1 an
enhanced plating efficiency was observed for A431
(P<0.05 for enzyme cocktail 3; P<0.025 for
enzyme cocktails 2 and 4) and ME180 tumours
(P<0.05 for enzyme cocktail 3; P<0.025 for
enzyme cocktail 4) (Figure 2a). However, based on
plating efficiency alone, no clear distinction could
be demonstrated for HEp3 tumours dissociated
with enzyme cocktails 1-4. For Col 12 tumours,
dissociation with enzyme cocktails 3 and 4 resulted
in slightly increased plating efficiencies as compared
to the results obtained with cocktails 1 and 2
(P<0.05).
The inclusion of up to 104 lethally irradiated
(HR) tumour cells in the clonogenic assay produced
variable results (Figure 2b). No change in plating
efficiency could be demonstrated for MEl80 cells
isolated by different enzyme techniques and plated
those obtained with
with and without HR cells (Figure 2a vs. 2b).
Conversely, the inclusion of HR cells improved the
plating efficiency of A431 cells isolated using each
of the enzyme cocktails. The plating efficiencies of
each tumour were corrected to account for the
varying proportions of tumour cells recovered with
each enzyme cocktail (Figure 3). For Coll2 and
HEp3 tumours the corrected plating efficiencies
were similar for all enzyme cocktails tested.
However, for A431 tumours, dissociation with
enzyme cocktail 2 resulted in an improved corrected
plating efficiency relative to that observed with
enzyme cocktails 1 or 3 (P<0.05). For ME180
tumours, the corrected plating efficiency after
dissociation with enzyme cocktail 1 was similar to
that of enzyme cocktails 2 and 3, but was increased
as compared to that of enzyme cocktail 4
(P<0.05).
Each enzyme cocktail was also compared for its
ability to release the greatest number of clonogenic
cells g-1 tumour (Figure 4). For Co 12, A431 and
ME180 tumours, enzyme cocktail 1 was markedly
superior to the other cocktails tested (P values
ranged from <0.05 to <0.0025). However, for
HEp3 tumours, comparable clonogenic cell yields
were found when all four enzyme cocktails were
compared.
Tumour heterogeneity
The data presented in Table I indicate that different






CoIl2 HEp3 A431 ME180
Figure 2 Uncorrected plating efficiencies of tumours
dissociated with different enzyme cocktails and plated
in the absence (a) or in the presence (b) of lethally
irradiated (HR) cells. Note the difference in the y-axis.
Mean+ s.e. provided for 3 or more determinations.










recovered using different enzyme dissociation
techniques. This was most strikingly demonstrated
in A431 tumours in which the percentage of
tumour cells recovered ranged from 10% (for
enzyme cocktail 2) to an average of 55% (for
enzyme cocktail 1) (P<0.01). Concomitantly, the
recovery of the various types of host cells
associated with A431 tumours varied markedly.
The relative proportions of macrophages remained
constant when the four enzyme cocktails were
compared. However, the number of neutrophils
ranged from average values of 17% (for enzyme
cocktail 1) to 71% (for enzyme cocktail 2)
(P<0.01). While the changes in the other tumour
models tested were nowhere near as extreme as
those seen in the A431 tumours, differences in the
proportions of host and tumour cells still were
observed. Similar to the morphometric evaluations,
FCM analysis of the cell populations obtained from
each type of tumour using different dissociation
techniques suggested that different proportions of
G1, S and G2M tumour cells were recovered (Table
II). For example, aberrant DNA distribution
profiles were especially prominent in ME180
tumours as indicated by the reduced yield of G1
tumour cells following treatment with enzyme
cocktail 4 and by the significant variation in
numbers of S and G2M tumour cells among the
four cell preparations analyzed.
The heterogeneity in cell recovery and plating
efficiency which was described for ME180, A431,
Col12 and HEp3 tumours was also observed when
tumours derived from two sublines of HEp3 cells
were compared. The HEp3 KSC1.1 and
HEp3SC2LM cell lines originated from HEp3 cells
passaged in a chick embryo and from a HEp3 lung
metastasis in a nude mouse, respectively, and were
chosen to determine the fidelity of parental
Iv
CoIl2 HEp3 A431 ME180
Figure 3 Plating efficiencies of tumours corrected for varying proportions of neoplastic cells recovered




























Co12 HEp3 A431 ME180
Figure 4 Total number of clonogenic cells recovered per g of tumour following dissociation of the tumour
with different enzyme cocktails. For interpretion ofcross-hatching see Figure 1 (footnote).
Table II The percentage of G1, S and G2M cells
recovered from each tumour following dissociation with
each enzyme cocktail.
Gi S G2M
(#1) 64.3 28.9 6.8
Co 12 (#2) 41.4 43.7 14.9 (#3) 40.3 37.4 22.3
(#4) 64.1 32 3.9
(#1) 65.5 18.9 15.6
Hep3 (#2) 88.6 7.1 4.3 (#3) 64.8 24.4 10.8
(#4) 78.2 18.5 3.3
(#1) 52.7 41.6 5.7
A431 (#2) 64.2 34.9 0.9 (#3) 58.4 33.9 7.7
(#4) 59.6 35.9 4.5
(#1) 91 1.3 6.7
ME180 (2) 70.6 20 9.4 (#3) 80.9 10 9.1
(#4) 66.4 32.3 1.3
characteristics such as plating efficiency and
percentage of tumour versus host cells, following
dissociation with different enzyme techniques. The
data provided in Table III show that the use of
different enzyme cocktails results in a greater
variation in both total cell recovery and plating
efficiency for the HEp3 tumour sublines than was
observed for the original tumour. In addition, the
relatively constant proportions of neoplastic cells
recovered from HEp3 tumours using different
enzyme cocktails was not observed when the two
sublines of HEp3 cells were analyzed. Variations in
the proportions of different types of host cells
recovered following different enzyme dissociations
were also noted for the HEp3 tumour sublines. For
example, while the proportion of neutrophils in
HEp3 tumours separated using different enzyme
cocktails ranged from 10-16%, in the tumours
derived from different HEp3 sublines, the
proportion of neutrophils recovered ranged from
19% to 84% depending upon which enzyme
cocktail was used for tumour dissociation.620 M.J. ALLALUNIS-TURNER AND D.W. SIEMANN
Table III Comparison of HEp3 parental and HEp3 sub-line tumour characteristics. Mean+s.e. provided for three or
more determinations.
Enzyme Cells (x 107)g 1
cocktail tumour P.E. (x 10-2) % Tumour % Macrophage % Neutrophil Lymphocyte
HEp3 1 3.9+1.1 5.5+1.8 64+8 20+1 13+7 3+1
2 2.3+0.5 5.0+2.5 72+ 12 12+1 16+12 1+1
3 2.1+1.2 9.6+1.7 61+5 28+2 10+4 2+1
4 2.3+0.7 8.5+4.7 70+7 14+1 15+8 2+0.5
HEp3 1 5.0 NDa 34 7 58 10
KSC1.1 2 4.4 NDa 55 8 36 7
3 4.3 NDa 10 2 84 4
4 8.6 NDa 52 2 44 2
HEp3 1 4.7+1.1 6.1+2.7 43+5 23+8 30+10 3+0.5
SC2LM 2 3.2+0.3 11.8+3.2 56+6 19+10 19+4 6+3
3 1.9+0.2 6.8+2.7 34+5 17+1 49+5 3+1
4 4.8+2.0 11.0+2.9 65+7 13+2 22+7 3+1
aNot determined.
Discussion
These studies have demonstrated that marked
variation in total cell recovery, plating efficiency
and host versus tumour cell ratio can be observed
when the same tumour is dissociated with different
enzyme cocktails. In addition, significant variation
in these parameters exists among the different
epidermoid tumours tested. Although for each
tumour tested, enzyme cocktail 1 consistently
produced total cell yields which were two-fold
greater than those observed with the other enzyme
preparations, the total cell yield among the four
tumours also varied by a factor of 2. With all
enzyme cocktails tested, some pieces of tumour
remained undissociated. However, preliminary
experiments with enzyme cocktail 1 indicated that
incubation times of more than 1 h did not result in
the release of significantly more cells. The effect of
variation in incubation time on the cell recovery
with other enzyme cocktails has yet to be
determined. The use of different enzyme cocktails
also modified the corrected plating efficiencies of
the tumours tested. These results were somewhat
unexpected. If the variation in the effect of different
enzyme cocktails was limited to differences in total
number of cells recovered, one would expect that
the plating efficiency of these cells, when corrected
for the number of tumour cells present in a given
cell suspension, would have been equivalent.
However, our results indicate that the use of
different enzyme dissociation techniques modifies
the plating efficiency. For example, under optimum
conditions (Figure 3) the plating efficiency of
Coil2 and HEp3 tumours is relatively constant for
all enzyme preparations. However, in the case of
ME180 tumours, a significant decrease in plating
efficiency was observed when tumours were
dissociated with enzyme cocktail 4, while for A431
tumours, cocktail 2 was superior. In these studies,
the same in vitro plating technique was used for all
tumours. It is not clear whether this technique
affords optimum growth potential for all of the
tumour and enzyme combinations studied. In
addition, current studies do not allow us to
distinguish between the possibilities that for ME180
tumours, in particular, these observed differences
are due to the enzyme cocktails recovering
quantitatively fewer tumour cells which are capable
of forming colonies in agar or that these enzyme
preparations are themselves cytotoxic to clonogenic
cells derived from this tumour. While it is possible
that the plating efficiencies might be improved by a
brief holding period to allow for the repair of
enzyme-induced damage, such a technique would
not be suitable for use in studies which assessed the
therapeutic effectiveness of radiation or
chemotherapeutic agents on tumour cell survival.
While the above variations in plating efficiency
were observed for tumours plated in the presence of
lethally irradiated (HR) cells, it was noted that the
choice of enzyme dissociation technique was able to
alter the requirements for HR cells in the
clonogenic assay (Figure 2). HR cells are thought
to improve the plating efficiency of most tumours
by providing an as yet unidentified source of
growth factors (Courtenay, 1983) or by increasing
the oxygen consumption in the culture, thereby
lowering the oxygen tension, a condition which is
regarded by some investigators as favouring tumour
growth in vitro (Walls&Twentyman, 1985). In these
studies, the addition of up to 104 HR cells to theXENOGRAFT CELL RECOVERY AFTER ENZYME DISSOCIATION 621
cultures did not uniformly improve the plating
efficiency of the tumours studied. For ME180
tumours, no difference in plating efficiency was
observed when cells were plated with or without
HR cells. Conversely, for A431 tumours, (i) the
addition of HR cells improved all plating
efficiencies, and (ii) resulted in all plating
efficiencies being approximately equal. For Col12
and HEp3 tumours, only the plating efficiency of
cells obtained using enzyme cocktails I and 2, or 1,
respectively, were improved by the addition of HR
cells. It remains to be determined whether an
increase in the number of HR cells added to the
cultures would have improved the plating efficiency
of tumours initially unaffected by the addition of
HR cells. Nonetheless, these results suggest that for
some tumours, a given enzyme cocktail may modify
a tumour cell's ability to respond to autocrine
growth factors, or may impair the ability of the
irradiated cells themselves to produce and release
these factors.
The experiments which analyzed the types of cells
present in the cell suspensions obtained following
tumour dissociation demonstrate that different
enzyme preparations can recover different pro-
portions of host and tumour cells. Siemann et al.
(1981) have demonstrated that murine tumours
can contain appreciable numbers (30-60%) of host
cells. Also using murine tumours it has been shown
that the recovery of host cell populations from a
tumour can be altered by the use of different
enzyme dissociation techniques (Russell et al., 1976;
Siemann et al., 1981). In our experiments, the
percentage of tumour cells in a given cell
preparation was relatively constant for HEp3,
Col 12 and ME180 tumours (Table I). However,
recovery of A431 tumour cells varied widely when
the results obtained following different enzyme
dissociation techniques were compared (Table I).
When enzyme cocktail 4 was used, few intact
tumour or host cells could be identified, whereas
when this same enzyme cocktail was used with the
other tumours, cell harvests of 50-70% tumour
cells were obtained (Table I). The FCM analysis of
the cell suspensions obtained with different enzyme
cocktails also supports the hypothesis that different
populations of cells can be obtained from the same
tumour specimen when different enzyme cocktails
are used.
In summary, the present experiments have
demonstrated that the choice of an enzyme
dissociation technique can modify factors such as
host and neoplastic cell yields from human tumour
xenografts and point to the need for careful
characterization of each tumour system before it
can be used to address questions of basic human
tumour biology or response of tumours to therapy.
In our studies, tumour cell plating efficiency
expressed as the number of clonogenic cells g-1
tumour was the endpoint used to assess the efficacy
of the four different enzyme dissociation tech-
niques. Using this criteria, enzyme cocktail 1 was
found to be superior to the other enzyme prepara-
tions tested. However, these results should be inter-
preted as applying particularly to these tumours
and this biological endpoint. It is possible, as
suggested by Steel and Peckham (1980), that other
dissociation techniques would provide superior
results if different tumours or different endpoints
are used. For example, xenografted tumours
derived from sarcomas may require a different
battery of enzyme to result in adequate tumour
dissociation. Similarly, if one were to study a
different biological endpoint, e.g., the amplification
of epidermal growth factor receptors on A431
tumours following different in vivo manipulations
(Stoscheck & Carpenter, 1983), one might observe
enzymes found most effective in the present investi-
gations to be ineffective at preserving the
expression of these receptors following tumour
dissociation. Similarly, different treatments such as
chemotherapy or irradiation may have differential
effects on the host versus neoplastic cell proportions
of a tumour. In such a case, a determination of the
relative proportions of host versus neoplastic cells
which persist in a tumour following treatment
would be necessary in order to accurately estimate
the corrected tumour cell plating efficiency. These
findings suggest that basic studies aimed at charac-
terizing the response of human xenograft material
to different dissociation techniques are necessary to
ensure that this aspect of the experimental
technique has been optimized for the tumours
under investigation.
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